Moderna Inc. buy UBS Group AG
Start price
19.02.25
/
50%
€34.80
Target price
19.02.26
€74.74
Performance (%)
21.67%
End price
20.02.26
€42.34
Summary
This prediction ended on 20.02.26 with a price of €42.34. The prediction had a final performance of 21.67%. UBS_Group_AG has a follow-up prediction for Moderna Inc. where he still thinks Moderna Inc. is a Buy. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Moderna Inc. | 106.702% | 106.702% | 394.454% |
| iShares Core DAX® | -1.586% | 5.028% | 6.332% |
| iShares Nasdaq 100 | -4.148% | -0.125% | 25.735% |
| iShares Nikkei 225® | -6.302% | 0.528% | 41.384% |
| iShares S&P 500 | -3.225% | 0.470% | 20.449% |
Comments by UBS_Group_AG for this prediction
In the thread Moderna Inc. diskutieren
Moderna, Inc. (NASDAQ: MRNA) had its price target lowered by analysts at UBS Group AG from $96.00 to $78.00. They now have a "buy" rating on the stock.
Ratings data for MRNA provided by MarketBeat
In the thread Trading Moderna Inc.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten